AlphaCrest Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-26,458
| Closed | -$748K | – | 32 |
|
|
2022
Q3 | $748K | Sell |
26,458
-7,907
| -23% | -$224K | 0.05% | 779 |
|
|
2022
Q2 | $762K | Buy |
34,365
+13,411
| +64% | +$297K | 0.04% | 785 |
|
|
2022
Q1 | $610K | Sell |
20,954
-7,977
| -28% | -$232K | 0.03% | 799 |
|
|
2021
Q4 | $951K | Buy |
28,931
+12,207
| +73% | +$401K | 0.04% | 817 |
|
|
2021
Q3 | $772K | Buy |
16,724
+127
| +0.8% | +$5.86K | 0.04% | 730 |
|
|
2021
Q2 | $915K | Buy |
+16,597
| New | +$915K | 0.04% | 706 |
|
|
2021
Q1 | – | Sell |
-5,460
| Closed | -$237K | – | 1168 |
|
|
2020
Q4 | $237K | Sell |
5,460
-7,840
| -59% | -$340K | 0.02% | 1006 |
|
|
2020
Q3 | $466K | Buy |
13,300
+6,683
| +101% | +$234K | 0.05% | 629 |
|
|
2020
Q2 | $354K | Buy |
+6,617
| New | +$354K | 0.06% | 550 |
|
|
2020
Q1 | – | Sell |
-5,865
| Closed | -$280K | – | 1002 |
|
|
2019
Q4 | $280K | Buy |
+5,865
| New | +$280K | 0.02% | 1093 |
|
|
2019
Q3 | – | Sell |
-17,510
| Closed | -$873K | – | 1240 |
|
|
2019
Q2 | $873K | Buy |
+17,510
| New | +$873K | 0.08% | 465 |
|